Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

What's new

Get the latest updates from What's new directly as they happen.

Follow now 267 followers

Latest posts

Last updated about 5 hours ago

Twelfth Industry Standing Group (ISG) meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, from 28 March 2025, 09:00 (CET) to 28 March 2025, 14:00 (CET)

about 5 hours ago

Twelfth Industry Standing Group (ISG) meeting, Online, European Medicines Agency, Amsterdam, the...

Thirteenth meeting of the industry stakeholder platform on research and development support, European Medicines Agency, Amsterdam, the Netherlands, 2 December 2024

about 5 hours ago

Thirteenth meeting of the industry stakeholder platform on research and development support...

Highlight report - 13th Industry stakeholder platform on research and development support

about 5 hours ago

Highlight report - 13th Industry stakeholder platform on research and development support

SMS guidance for external users

about 6 hours ago

SMS guidance for external users

PSUSA/00002942/202406

about 6 hours ago

PSUSA/00002942/202406

Human medicines European public assessment report (EPAR): Roclanda, latanoprost / netarsudil, Date of authorisation: 07/01/2021, Revision: 8, Status: Authorised

about 6 hours ago

Human medicines European public assessment report (EPAR): Roclanda, latanoprost / netarsudil, Date...

Human medicines European public assessment report (EPAR): Ajovy, fremanezumab, Date of authorisation: 28/03/2019, Revision: 13, Status: Authorised

about 6 hours ago

Human medicines European public assessment report (EPAR): Ajovy, fremanezumab, Date of authorisation...

Human medicines European public assessment report (EPAR): SomaKit TOC, edotreotide, Date of authorisation: 08/12/2016, Revision: 21, Status: Authorised

about 7 hours ago

Human medicines European public assessment report (EPAR): SomaKit TOC, edotreotide, Date of...

Human medicines European public assessment report (EPAR): Stoboclo, denosumab, Date of authorisation: 14/02/2025, Status: Authorised

about 7 hours ago

Human medicines European public assessment report (EPAR): Stoboclo, denosumab, Date of authorisation...

Human medicines European public assessment report (EPAR): Avtozma, tocilizumab, Date of authorisation: 14/02/2025, Status: Authorised

about 8 hours ago

Human medicines European public assessment report (EPAR): Avtozma, tocilizumab, Date of authorisation...

Human medicines European public assessment report (EPAR): Rivastigmine Sandoz, rivastigmine, Date of authorisation: 10/12/2009, Revision: 18, Status: Authorised

about 8 hours ago

Human medicines European public assessment report (EPAR): Rivastigmine Sandoz, rivastigmine, Date of...

Human medicines European public assessment report (EPAR): Rivastigmine Hexal, rivastigmine, Date of authorisation: 11/12/2009, Revision: 19, Status: Authorised

about 8 hours ago

Human medicines European public assessment report (EPAR): Rivastigmine Hexal, rivastigmine, Date of...